Affiliation:
1. Department of Otolaryngology–Head & Neck Surgery University of Alabama at Birmingham Birmingham Alabama USA
2. University of California Irvine School of Medicine University of California Irvine Irvine California USA
3. Heersink School of Medicine University of Alabama at Birmingham Birmingham Alabama USA
4. Department of Otolaryngology–Head & Neck Surgery University of Colorado School of Medicine Aurora Colorado USA
5. Department of Otolaryngology–Head & Neck Surgery University of California Irvine Irvine California USA
6. O'Neal Comprehensive Cancer Center University of Alabama at Birmingham Birmingham Alabama USA
Abstract
AbstractObjectiveTo determine if antithrombotic therapy improves head and neck microvascular free flap survival following anastomotic revision.Study DesignA retrospective review of all patients with microvascular free tissue transfer to the head and neck between August 2013 and July 2021.SettingOtolaryngology–Head and Neck Surgery Departments at University of Alabama at Birmingham, University of Colorado, and University of California Irvine.MethodsPerioperative use of anticoagulation, antiplatelets, intraoperative heparin bolus, tissue plasminogen activator (tPA) and vasopressor use, and leech therapy were collected plus microvascular free flap outcomes. The primary endpoint was free flap failure. Analyses of free flaps that underwent anastomotic revision with or without thrombectomy were performed.ResultsA total of 843 microvascular free flaps were included. The overall rate of flap failure was 4.0% (n = 34). The overall rate of pedicle anastomosis revision (artery, vein, or both) was 5.0% (n = 42) with a failure rate of 47.6% (n = 20) after revision. Anastomotic revision significantly increased the risk of flap failure (odds ratio [OR] 52.68, 95% confidence interval [CI] [23.90, 121.1], p < .0001) especially when both the artery and vein were revised (OR 9.425, 95% CI [2.117, 52.33], p = .005). Free flap failure after the anastomotic revision was not affected by postoperative antiplatelet therapy, postoperative prophylactic anticoagulation, intraoperative heparin bolus, tPA, and therapeutic anticoagulation regardless of which vessels were revised and if a thrombus was identified.ConclusionIn cases of microvascular free tissue transfer pedicle anastomotic revision, the use of antithrombotic therapy does not appear to significantly change free flap survival outcomes.
Subject
Otorhinolaryngology,Surgery
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献